Michael Devereux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael Devereux has a total of 296 co-authors. Here are the top co-authors by number of shared publications:
Malachy McCann
Chemistry Department, Maynooth University, Co., Kildare, Ireland
74 shared publications- Vickie McKee
Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark
29 shared publications - Kevin Kavanagh
Department of Biology, Maynooth University, W23 F2K8 Maynooth, Ireland
27 shared publications - Andrew Kellett
Research Ireland Centre for Pharmaceuticals School of Chemical Sciences Dublin City University Dublin Ireland
22 shared publications - Orla Howe
School of Biological, Health and Sports Sciences, Technological University Dublin, Dublin, Ireland
20 shared publications - Bernadette S. Creaven
Centre for AMR and One Health Research Technological University Dublin Tallaght Campus Dublin D24 FKT9 Ireland
15 shared publications
Latest Publications
- 25 January 2026
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 18 (1)
Raman spectroscopic profiling of cell death induced by cytotoxic copper(II), manganese(II), and silver(I) complexes containing dicarboxylate and 1,10-phenanthroline ligands: novel insights into in vitro mechanisms
Raman spectroscopy is a label-free, chemically selective technique increasingly employed to probe intracellular biochemical changes associated with drug exposure. Herein, Raman microspectroscopy was applied to evaluate the in vitro responses of MCF-7 (cancerous) and MCF-12A (noncancerous) breast cells to a series of cytotoxic copper(II) (Cu(II)), manganese(II) (Mn(II)), and silver(I) (Ag(I)) complexes containing dicarboxylate and 1,10-phenathroline ligands. Their spectral responses were analysed using principal component analysis (PCA), establishing distinct molecular fingerprints for each metal complex, reflecting divergent mechanisms of action (MOAs). The Cu(II) complexes produced signatures consistent with canonical apoptosis, including reduced DNA backbone vibrations at ∼785 cm⁻¹ and protein conformational changes at ∼1660 cm⁻¹. The Mn(II) complexes demonstrated features of oxidative stress (∼1450 and 1180 cm⁻¹) and spectral features associated with autophagy (∼718 cm⁻¹), in addition to signatures of an apoptotic response like those observed by the Cu(II) analogues, supporting a multimodal mechanism. In contrast, Ag(I) complexes elicited distinct biochemical alterations suggestive of non-canonical pathways, including markers linked to cholesterol metabolism at ∼703 cm⁻¹ and steroid-related activity indicated by multiple features > 1600 cm⁻¹. These spectral distinctions shed light on the role of different types of metal centres in modulating downstream cellular responses and underscore Raman spectroscopy’s utility in resolving subtle yet functionally relevant biochemical differences across this series of complexes. Collectively, these findings provide novel insights into the MOAs of this class of complex and support the broader application of Raman spectroscopy to inform future design and evaluation of metal-based cytotoxic agents.
- 25 January 2026
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 18 (1)
Raman spectroscopic profiling of cell death induced by cytotoxic copper(II), manganese(II), and silver(I) complexes containing dicarboxylate and 1,10-phenanthroline ligands: novel insights into in vitro mechanisms
Raman spectroscopy is a label-free, chemically selective technique increasingly employed to probe intracellular biochemical changes associated with drug exposure. Herein, Raman microspectroscopy was applied to evaluate the in vitro responses of MCF-7 (cancerous) and MCF-12A (noncancerous) breast cells to a series of cytotoxic copper(II) (Cu(II)), manganese(II) (Mn(II)), and silver(I) (Ag(I)) complexes containing dicarboxylate and 1,10-phenathroline ligands. Their spectral responses were analysed using principal component analysis (PCA), establishing distinct molecular fingerprints for each metal complex, reflecting divergent mechanisms of action (MOAs). The Cu(II) complexes produced signatures consistent with canonical apoptosis, including reduced DNA backbone vibrations at ∼785 cm⁻¹ and protein conformational changes at ∼1660 cm⁻¹. The Mn(II) complexes demonstrated features of oxidative stress (∼1450 and 1180 cm⁻¹) and spectral features associated with autophagy (∼718 cm⁻¹), in addition to signatures of an apoptotic response like those observed by the Cu(II) analogues, supporting a multimodal mechanism. In contrast, Ag(I) complexes elicited distinct biochemical alterations suggestive of non-canonical pathways, including markers linked to cholesterol metabolism at ∼703 cm⁻¹ and steroid-related activity indicated by multiple features > 1600 cm⁻¹. These spectral distinctions shed light on the role of different types of metal centres in modulating downstream cellular responses and underscore Raman spectroscopy’s utility in resolving subtle yet functionally relevant biochemical differences across this series of complexes. Collectively, these findings provide novel insights into the MOAs of this class of complex and support the broader application of Raman spectroscopy to inform future design and evaluation of metal-based cytotoxic agents.
- Open Access
- 24 December 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (1) , 4
In Vitro Assessment of the Combined Activity of Amphotericin B and Cu2+-1,10-Phenanthroline-5,6-dione Coordination Compound Against Leishmania amazonensis Promastigotes
Leishmaniasis is a severe parasitic disease transmitted by sandflies that affects both humans and animals, with clinical manifestations ranging from cutaneous lesions to life-threatening visceral involvement. Current treatments are limited by toxicity, high cost, and the emergence of drug-resistant strains, underscoring the need for safer and more effective therapeutic strategies. In this study, we investigated the antiparasitic potential of combining Amphotericin B, a drug commonly used for leishmaniasis treatment, with 1,10-phenanthroline-5,6-dione (phendione) coordinated to copper (Cu2+-phendione), an experimental coordination compound, against Leishmania amazonensis promastigotes. The combination markedly impaired parasite proliferation, disrupted ultrastructural integrity, and interfered with metabolic activity. Mechanistic analyses revealed the presence of autophagosomes and pronounced mitochondrial alterations in treated parasites, suggesting the induction of cellular stress and the disruption of essential survival pathways. In addition, the treatment reduced the association index with THP-1 cells, indicating a decrease in parasite infectivity. Collectively, these findings demonstrate that the combination of Cu2+-phendione and Amphotericin B exerts potent antiparasitic effects through multiple mechanisms. Our results also showed that Cu2+-phendione combined with AmB displayed an additive effect, although the isobologram suggested that certain ratios approached synergy. The results support the potential of this combination as a novel chemotherapeutic approach against leishmaniasis and provide a basis for future in vivo studies to evaluate safety, efficacy, and optimal dosing strategies.
- 24 December 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (1) , 4
Open AccessIn Vitro Assessment of the Combined Activity of Amphotericin B and Cu2+-1,10-Phenanthroline-5,6-dione Coordination Compound Against Leishmania amazonensis Promastigotes
Leishmaniasis is a severe parasitic disease transmitted by sandflies that affects both humans and animals, with clinical manifestations ranging from cutaneous lesions to life-threatening visceral involvement. Current treatments are limited by toxicity, high cost, and the emergence of drug-resistant strains, underscoring the need for safer and more effective therapeutic strategies. In this study, we investigated the antiparasitic potential of combining Amphotericin B, a drug commonly used for leishmaniasis treatment, with 1,10-phenanthroline-5,6-dione (phendione) coordinated to copper (Cu2+-phendione), an experimental coordination compound, against Leishmania amazonensis promastigotes. The combination markedly impaired parasite proliferation, disrupted ultrastructural integrity, and interfered with metabolic activity. Mechanistic analyses revealed the presence of autophagosomes and pronounced mitochondrial alterations in treated parasites, suggesting the induction of cellular stress and the disruption of essential survival pathways. In addition, the treatment reduced the association index with THP-1 cells, indicating a decrease in parasite infectivity. Collectively, these findings demonstrate that the combination of Cu2+-phendione and Amphotericin B exerts potent antiparasitic effects through multiple mechanisms. Our results also showed that Cu2+-phendione combined with AmB displayed an additive effect, although the isobologram suggested that certain ratios approached synergy. The results support the potential of this combination as a novel chemotherapeutic approach against leishmaniasis and provide a basis for future in vivo studies to evaluate safety, efficacy, and optimal dosing strategies.
- Open Access
- 28 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (12) , 1819
Biological Activity of Silver(I)-1,10-Phenanthroline Complexes Against Fonsecaea pedrosoi: In Silico Predictions, In Vitro Macrophage Interactions and In Vivo Efficacy in Galleria mellonella
Background/Objectives: Fonsecaea pedrosoi causes chromoblastomycosis, a neglected chronic subcutaneous mycosis that remains difficult to treat. In this study, we evaluated the toxicity and the antifungal effect of [Ag(1,10-phenanthroline)2]ClO4 (Ag-phen) and [Ag2(3,6,9-trioxaundecanedioate)(1,10-phenanthroline)4]·EtOH (Ag-tdda-phen) against F. pedrosoi using in silico, in vitro and in vivo approaches. Methods: Pharmacokinetic and toxicological parameters were predicted using ADMETlab 2.0. The toxicity of the complexes was assessed using sheep red blood cells, RAW 264.7 macrophage cells, and larvae of Tenebrio molitor and Galleria mellonella. The effects of these complexes on macrophage adhesion capacity and reactive oxygen species (ROS) production were also investigated using Giemsa staining and dichlorofluorescein diacetate, respectively. In addition, their impact on the survival of G. mellonella larvae infected with conidia was evaluated. Results: Overall, computational analyses predicted favorable tolerability profiles for both complexes. In vitro assays with red blood cells and macrophages demonstrated that they exhibited selectivity indexes >10 against F. pedrosoi. These findings were corroborated by in vivo experiments in which both complexes were injected into insect larvae; the complexes demonstrating good tolerability at concentrations of up to 500 mg/L. Macrophage infection assays revealed that Ag-tdda-phen and Ag-phen markedly reduced the number of intracellular conidia. These effects appear to be associated with oxidative stress, as macrophage production of ROS significantly increased following treatment with the complexes. Furthermore, Ag-tdda-phen improved the survival of G. mellonella larvae infected with F. pedrosoi, demonstrating a protective effect. Conclusions: Collectively, our findings support the notion that silver(I)-phen derivatives represent promising candidates for the development of therapeutic options against CBM infections caused by F. pedrosoi.
- 28 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (12) , 1819
Open AccessBiological Activity of Silver(I)-1,10-Phenanthroline Complexes Against Fonsecaea pedrosoi: In Silico Predictions, In Vitro Macrophage Interactions and In Vivo Efficacy in Galleria mellonella
Background/Objectives: Fonsecaea pedrosoi causes chromoblastomycosis, a neglected chronic subcutaneous mycosis that remains difficult to treat. In this study, we evaluated the toxicity and the antifungal effect of [Ag(1,10-phenanthroline)2]ClO4 (Ag-phen) and [Ag2(3,6,9-trioxaundecanedioate)(1,10-phenanthroline)4]·EtOH (Ag-tdda-phen) against F. pedrosoi using in silico, in vitro and in vivo approaches. Methods: Pharmacokinetic and toxicological parameters were predicted using ADMETlab 2.0. The toxicity of the complexes was assessed using sheep red blood cells, RAW 264.7 macrophage cells, and larvae of Tenebrio molitor and Galleria mellonella. The effects of these complexes on macrophage adhesion capacity and reactive oxygen species (ROS) production were also investigated using Giemsa staining and dichlorofluorescein diacetate, respectively. In addition, their impact on the survival of G. mellonella larvae infected with conidia was evaluated. Results: Overall, computational analyses predicted favorable tolerability profiles for both complexes. In vitro assays with red blood cells and macrophages demonstrated that they exhibited selectivity indexes >10 against F. pedrosoi. These findings were corroborated by in vivo experiments in which both complexes were injected into insect larvae; the complexes demonstrating good tolerability at concentrations of up to 500 mg/L. Macrophage infection assays revealed that Ag-tdda-phen and Ag-phen markedly reduced the number of intracellular conidia. These effects appear to be associated with oxidative stress, as macrophage production of ROS significantly increased following treatment with the complexes. Furthermore, Ag-tdda-phen improved the survival of G. mellonella larvae infected with F. pedrosoi, demonstrating a protective effect. Conclusions: Collectively, our findings support the notion that silver(I)-phen derivatives represent promising candidates for the development of therapeutic options against CBM infections caused by F. pedrosoi.
- 15 November 2025
- Published by Springer Nature in BioMetals
- Vol. 39 (1) , 337-358
Autophagy-dependent cell death and immune responses induced by heteroleptic copper(II), manganese(II), and silver(I) complexes containing dicarboxylate and 1,10-phenanthroline ligands: novel insights from in vitro and in vivo models
Autophagy is a process that breaks down unwanted cellular components to maintain homeostasis. While it is defined as a ‘self-protection’ process, a disruption of autophagic mechanisms can lead to cellular death. Autophagy is interconnected with many other cellular processes including innate and adaptive immunity and can therefore have therapeutic potential as it can be modulated to control immune and other cellular responses. We therefore postulated the potential of our Cu(II), Mn(II) and Ag(I) complexes coordinated with 1,10-phenanthroline to interfere with the autophagy process and to induce an immune-response. Herein, we evaluated the ability of a series of heteroleptic complexes, [Cu2(oda)(phen)4](ClO4)2, [Cu(oda)(phen)2], [Ag2(oda)(phen)3], [Ag2(udda)(phen)3], and {[Mn2(oda)3(phen)4]2−[Mn2(oda)(phen)4(H2O)2]2+}(where:oda2− = octanedioate; udda2− = undecanedioate; and phen = 1,10-phenanthroline), to modulate autophagy in vitro using MCF-7 (breast cancer) and MCF-12A (non-tumorigenic breast) cell lines; alongside their in vivo immunomodulatory effects in the Galleria mellonella larva model. Differential autophagy induction was observed between the two cell types through quantitative flow cytometry and fluorescence microscopy of autophagosomes using GFP-LC3, with a pronounced upregulation in non-tumorigenic MCF-12A cells compared to cancerous MCF-7 cells, underscoring the context-dependent modes of action of these complexes. Among them, the Mn(II)-phen complex ({[Mn2(oda)3(phen)4]2−[Mn2(oda)(phen)4(H2O)2]2+}) was identified as the most potent inducer of autophagy in MCF-7 cells (p < 0.01), highlighting its unique mechanistic interaction within this breast cancer cell line, compared to the Cu(II) and Ag(I) analogues. In vivo characterisation of the complexes in the larvae of G. mellonella revealed a high tolerance and broad therapeutic windows were established. Notably, the Ag(I)-phen complex [Ag2(udda)(phen)3] was determined as the most well-tolerated complex, with a 24-h LD50 of 864.3 µg/mL, exemplifying the pronounced tolerance of the complexes in contrast to previously reported in vitro cytotoxicity at distinctly low micro-molar concentrations. Analysis of changes in the haemocyte density, an established marker of immune response, revealed significant immune activation in G. mellonella, particularly with the Ag(I) ([Ag2(oda)(phen)3] and [Ag2(udda)(phen)3]) and Mn(II) ({[Mn2(oda)3(phen)4]2−[Mn2(oda)(phen)4(H2O)2]2+}) complexes (p < 0.001). This study offers novel insights into the interplay between autophagy and immune modulation building upon our recent in vitro apoptosis study with these complexes. Our work establishes a compelling link between autophagy and modulation of immune activation and provides further biological insights on the unique and metal-specific roles of these complexes in shaping cellular and systemic responses.- 15 November 2025
- Published by Springer Nature in BioMetals
- Vol. 39 (1) , 337-358
Autophagy-dependent cell death and immune responses induced by heteroleptic copper(II), manganese(II), and silver(I) complexes containing dicarboxylate and 1,10-phenanthroline ligands: novel insights from in vitro and in vivo models
Autophagy is a process that breaks down unwanted cellular components to maintain homeostasis. While it is defined as a ‘self-protection’ process, a disruption of autophagic mechanisms can lead to cellular death. Autophagy is interconnected with many other cellular processes including innate and adaptive immunity and can therefore have therapeutic potential as it can be modulated to control immune and other cellular responses. We therefore postulated the potential of our Cu(II), Mn(II) and Ag(I) complexes coordinated with 1,10-phenanthroline to interfere with the autophagy process and to induce an immune-response. Herein, we evaluated the ability of a series of heteroleptic complexes, [Cu2(oda)(phen)4](ClO4)2, [Cu(oda)(phen)2], [Ag2(oda)(phen)3], [Ag2(udda)(phen)3], and {[Mn2(oda)3(phen)4]2−[Mn2(oda)(phen)4(H2O)2]2+}(where:oda2− = octanedioate; udda2− = undecanedioate; and phen = 1,10-phenanthroline), to modulate autophagy in vitro using MCF-7 (breast cancer) and MCF-12A (non-tumorigenic breast) cell lines; alongside their in vivo immunomodulatory effects in the Galleria mellonella larva model. Differential autophagy induction was observed between the two cell types through quantitative flow cytometry and fluorescence microscopy of autophagosomes using GFP-LC3, with a pronounced upregulation in non-tumorigenic MCF-12A cells compared to cancerous MCF-7 cells, underscoring the context-dependent modes of action of these complexes. Among them, the Mn(II)-phen complex ({[Mn2(oda)3(phen)4]2−[Mn2(oda)(phen)4(H2O)2]2+}) was identified as the most potent inducer of autophagy in MCF-7 cells (p < 0.01), highlighting its unique mechanistic interaction within this breast cancer cell line, compared to the Cu(II) and Ag(I) analogues. In vivo characterisation of the complexes in the larvae of G. mellonella revealed a high tolerance and broad therapeutic windows were established. Notably, the Ag(I)-phen complex [Ag2(udda)(phen)3] was determined as the most well-tolerated complex, with a 24-h LD50 of 864.3 µg/mL, exemplifying the pronounced tolerance of the complexes in contrast to previously reported in vitro cytotoxicity at distinctly low micro-molar concentrations. Analysis of changes in the haemocyte density, an established marker of immune response, revealed significant immune activation in G. mellonella, particularly with the Ag(I) ([Ag2(oda)(phen)3] and [Ag2(udda)(phen)3]) and Mn(II) ({[Mn2(oda)3(phen)4]2−[Mn2(oda)(phen)4(H2O)2]2+}) complexes (p < 0.001). This study offers novel insights into the interplay between autophagy and immune modulation building upon our recent in vitro apoptosis study with these complexes. Our work establishes a compelling link between autophagy and modulation of immune activation and provides further biological insights on the unique and metal-specific roles of these complexes in shaping cellular and systemic responses.- Open Access
- 17 March 2025
- Published by Springer Nature in BioMetals
- Vol. 38 (3) , 785-805
Apoptotic cell death induced by copper (II), manganese (II) and silver (I) complexes containing bridging dicarboxylate and 1,10-phenanthroline ligands: one of the multi-modes of anticancer activity?
Cu(II), Mn(II) and Ag(I) complexes incorporating bridging dicarboxylate and 1,10-phenanthroline ligands have exhibited anti-cancer potential with significant in vitro and in vivo cytotoxic efficacies. Our study focuses on regulated cell death process of apoptosis as a mode of action of the anti-cancer activity by the complexes. Cytotoxicity screening of the complexes demonstrated all the metal-dicarboxylate-phenanthroline complexes exhibit superior activity compared to their non-phenanthroline containing precursors, in addition to cisplatin. The Cu(II) and Mn(II) complexes were shown to induce reactive oxygen species (ROS) but this was not observed for the Ag(I) analogues. Furthermore, apoptosis was found to be induced by all the metal-phenanthroline complexes to varying degrees contingent on the type of metal centre in the complex. Apoptotic gene expression analysis established the predominant activation of the intrinsic apoptotic pathway, with co-stimulation of the extrinsic pathway observed in some cases. The mechanistic data provided within this study highlights the multi-modal activity of the metal-phenanthroline complexes contingent on the type of metal present, warranting continued investigation of their biological modes of action beyond apoptosis induction.
- 17 March 2025
- Published by Springer Nature in BioMetals
- Vol. 38 (3) , 785-805
Open AccessApoptotic cell death induced by copper (II), manganese (II) and silver (I) complexes containing bridging dicarboxylate and 1,10-phenanthroline ligands: one of the multi-modes of anticancer activity?
Cu(II), Mn(II) and Ag(I) complexes incorporating bridging dicarboxylate and 1,10-phenanthroline ligands have exhibited anti-cancer potential with significant in vitro and in vivo cytotoxic efficacies. Our study focuses on regulated cell death process of apoptosis as a mode of action of the anti-cancer activity by the complexes. Cytotoxicity screening of the complexes demonstrated all the metal-dicarboxylate-phenanthroline complexes exhibit superior activity compared to their non-phenanthroline containing precursors, in addition to cisplatin. The Cu(II) and Mn(II) complexes were shown to induce reactive oxygen species (ROS) but this was not observed for the Ag(I) analogues. Furthermore, apoptosis was found to be induced by all the metal-phenanthroline complexes to varying degrees contingent on the type of metal centre in the complex. Apoptotic gene expression analysis established the predominant activation of the intrinsic apoptotic pathway, with co-stimulation of the extrinsic pathway observed in some cases. The mechanistic data provided within this study highlights the multi-modal activity of the metal-phenanthroline complexes contingent on the type of metal present, warranting continued investigation of their biological modes of action beyond apoptosis induction.
- Open Access
- 30 June 2023
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (7) , 348
Silver(I) and Copper(II) 1,10-Phenanthroline-5,6-dione Complexes as Promising Antivirulence Strategy against Leishmania: Focus on Gp63 (Leishmanolysin)
Leishmaniasis, caused by protozoa of the genus Leishmania, encompasses a group of neglected diseases with diverse clinical and epidemiological manifestations that can be fatal if not adequately and promptly managed/treated. The current chemotherapy options for this disease are expensive, require invasive administration and often lead to severe side effects. In this regard, our research group has previously reported the potent anti-Leishmania activity of two coordination compounds (complexes) derived from 1,10-phenanthroline-5,6-dione (phendione): [Cu(phendione)3].(ClO4)2.4H2O and [Ag(phendione)2].ClO4. The present study aimed to evaluate the effects of these complexes on leishmanolysin (gp63), a virulence factor produced by all Leishmania species that plays multiple functions and is recognized as a potential target for antiparasitic drugs. The results showed that both Ag-phendione (−74.82 kcal/mol) and Cu-phendione (−68.16 kcal/mol) were capable of interacting with the amino acids comprising the active site of the gp63 protein, exhibiting more favorable interaction energies compared to phendione alone (−39.75 kcal/mol) or 1,10-phenanthroline (−45.83 kcal/mol; a classical gp63 inhibitor) as judged by molecular docking assay. The analysis of kinetic parameters using the fluorogenic substrate Z-Phe-Arg-AMC indicated Vmax and apparent Km values of 0.064 µM/s and 14.18 µM, respectively, for the released gp63. The effects of both complexes on gp63 proteolytic activity were consistent with the in silico assay, where Ag-phendione exhibited the highest gp63 inhibition capacity against gp63, with an IC50 value of 2.16 µM and the lowest inhibitory constant value (Ki = 5.13 µM), followed by Cu-phendione (IC50 = 163 µM and Ki = 27.05 µM). Notably, pretreatment of live L. amazonensis promastigotes with the complexes resulted in a significant reduction in the expression of gp63 protein, including the isoforms located on the parasite cell surface. Both complexes markedly decreased the in vitro association indexes between L. amazonensis promastigotes and THP-1 human macrophages; however, this effect was reversed by the addition of soluble gp63 molecules to the interaction medium. Collectively, our findings highlight the potential use of these potent complexes in antivirulence therapy against Leishmania, offering new insights for the development of effective treatments for leishmaniasis.
- 30 June 2023
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (7) , 348
Open AccessSilver(I) and Copper(II) 1,10-Phenanthroline-5,6-dione Complexes as Promising Antivirulence Strategy against Leishmania: Focus on Gp63 (Leishmanolysin)
Leishmaniasis, caused by protozoa of the genus Leishmania, encompasses a group of neglected diseases with diverse clinical and epidemiological manifestations that can be fatal if not adequately and promptly managed/treated. The current chemotherapy options for this disease are expensive, require invasive administration and often lead to severe side effects. In this regard, our research group has previously reported the potent anti-Leishmania activity of two coordination compounds (complexes) derived from 1,10-phenanthroline-5,6-dione (phendione): [Cu(phendione)3].(ClO4)2.4H2O and [Ag(phendione)2].ClO4. The present study aimed to evaluate the effects of these complexes on leishmanolysin (gp63), a virulence factor produced by all Leishmania species that plays multiple functions and is recognized as a potential target for antiparasitic drugs. The results showed that both Ag-phendione (−74.82 kcal/mol) and Cu-phendione (−68.16 kcal/mol) were capable of interacting with the amino acids comprising the active site of the gp63 protein, exhibiting more favorable interaction energies compared to phendione alone (−39.75 kcal/mol) or 1,10-phenanthroline (−45.83 kcal/mol; a classical gp63 inhibitor) as judged by molecular docking assay. The analysis of kinetic parameters using the fluorogenic substrate Z-Phe-Arg-AMC indicated Vmax and apparent Km values of 0.064 µM/s and 14.18 µM, respectively, for the released gp63. The effects of both complexes on gp63 proteolytic activity were consistent with the in silico assay, where Ag-phendione exhibited the highest gp63 inhibition capacity against gp63, with an IC50 value of 2.16 µM and the lowest inhibitory constant value (Ki = 5.13 µM), followed by Cu-phendione (IC50 = 163 µM and Ki = 27.05 µM). Notably, pretreatment of live L. amazonensis promastigotes with the complexes resulted in a significant reduction in the expression of gp63 protein, including the isoforms located on the parasite cell surface. Both complexes markedly decreased the in vitro association indexes between L. amazonensis promastigotes and THP-1 human macrophages; however, this effect was reversed by the addition of soluble gp63 molecules to the interaction medium. Collectively, our findings highlight the potential use of these potent complexes in antivirulence therapy against Leishmania, offering new insights for the development of effective treatments for leishmaniasis.
- Open Access
Peptidases Are Potential Targets of Copper(II)-1,10-Phenanthroline-5,6-dione Complex, a Promising and Potent New Drug against Trichomonas vaginalis
Trichomonas vaginalis is responsible for 156 million new cases per year worldwide. When present asymptomatically, the parasite can lead to serious complications, such as development of cervical and prostate cancer. As infection increases the acquisition and transmission of HIV, the control of trichomoniasis represents an important niche for the discovery and development of new antiparasitic molecules. This urogenital parasite synthesizes several molecules that allow the establishment and pathogenesis of infection. Among them, peptidases occupy key roles as virulence factors, and the inhibition of these enzymes has become an important mechanism for modulating pathogenesis. Based on these premises, our group recently reported the potent anti-T. vaginalis action of the metal-based complex [Cu(phendione)3](ClO4)2.4H2O (Cu-phendione). In the present study, we evaluated the influence of Cu-phendione on the modulation of proteolytic activities produced by T. vaginalis by biochemical and molecular approaches. Cu-phendione showed strong inhibitory potential against T. vaginalis peptidases, especially cysteine- and metallo-type peptidases. The latter revealed a more prominent effect at both the post-transcriptional and post-translational levels. Molecular Docking analysis confirmed the interaction of Cu-phendione, with high binding energy (−9.7 and −10.7 kcal·mol−1, respectively) at the active site of both TvMP50 and TvGP63 metallopeptidases. In addition, Cu-phendione significantly reduced trophozoite-mediated cytolysis in human vaginal (HMVII) and monkey kidney (VERO) epithelial cell lineages. These results highlight the antiparasitic potential of Cu-phendione by interaction with important T. vaginalis virulence factors.
Open AccessPeptidases Are Potential Targets of Copper(II)-1,10-Phenanthroline-5,6-dione Complex, a Promising and Potent New Drug against Trichomonas vaginalis
Trichomonas vaginalis is responsible for 156 million new cases per year worldwide. When present asymptomatically, the parasite can lead to serious complications, such as development of cervical and prostate cancer. As infection increases the acquisition and transmission of HIV, the control of trichomoniasis represents an important niche for the discovery and development of new antiparasitic molecules. This urogenital parasite synthesizes several molecules that allow the establishment and pathogenesis of infection. Among them, peptidases occupy key roles as virulence factors, and the inhibition of these enzymes has become an important mechanism for modulating pathogenesis. Based on these premises, our group recently reported the potent anti-T. vaginalis action of the metal-based complex [Cu(phendione)3](ClO4)2.4H2O (Cu-phendione). In the present study, we evaluated the influence of Cu-phendione on the modulation of proteolytic activities produced by T. vaginalis by biochemical and molecular approaches. Cu-phendione showed strong inhibitory potential against T. vaginalis peptidases, especially cysteine- and metallo-type peptidases. The latter revealed a more prominent effect at both the post-transcriptional and post-translational levels. Molecular Docking analysis confirmed the interaction of Cu-phendione, with high binding energy (−9.7 and −10.7 kcal·mol−1, respectively) at the active site of both TvMP50 and TvGP63 metallopeptidases. In addition, Cu-phendione significantly reduced trophozoite-mediated cytolysis in human vaginal (HMVII) and monkey kidney (VERO) epithelial cell lineages. These results highlight the antiparasitic potential of Cu-phendione by interaction with important T. vaginalis virulence factors.
- Open Access
- 15 March 2023
- Published by MDPI AG in Journal of Fungi
- Vol. 9 (3) , 356
Silver(I) 1,10-Phenanthroline Complexes Are Active against Fonsecaea pedrosoi Viability and Negatively Modulate Its Potential Virulence Attributes
The genus Fonsecaea is one of the etiological agents of chromoblastomycosis (CBM), a chronic subcutaneous disease that is difficult to treat. This work aimed to evaluate the effects of copper(II), manganese(II) and silver(I) complexes coordinated with 1,10-phenanthroline (phen)/1,10-phenanthroline-5,6-dione (phendione) on Fonsecaea spp. Our results revealed that most of these complexes were able to inhibit F. pedrosoi, F. monophora and F. nubica conidial viability with minimum inhibitory concentration (MIC) values ranging from 0.6 to 100 µM. The most effective complexes against F. pedrosoi planktonic conidial cells, the main etiologic agent of CBM, were [Ag(phen)2]ClO4 and [Ag2(3,6,9-tdda)(phen)4].EtOH, (tdda: 3,6,9-trioxaundecanedioate), displaying MIC values equal to 1.2 and 0.6 µM, respectively. These complexes were effective in reducing the viability of F. pedrosoi biofilm formation and maturation. Silver(I)-tdda-phen, combined with itraconazole, reduced the viability and extracellular matrix during F. pedrosoi biofilm development. Moreover, both silver(I) complexes inhibited either metallo- or aspartic-type peptidase activities of F. pedrosoi as well as its conidia into mycelia transformation and melanin production. In addition, the complexes induced the production of intracellular reactive oxygen species in F. pedrosoi. Taken together, our data corroborate the antifungal action of metal-phen complexes, showing they represent a therapeutic option for fungal infections, including CBM.
- 15 March 2023
- Published by MDPI AG in Journal of Fungi
- Vol. 9 (3) , 356
Open AccessSilver(I) 1,10-Phenanthroline Complexes Are Active against Fonsecaea pedrosoi Viability and Negatively Modulate Its Potential Virulence Attributes
The genus Fonsecaea is one of the etiological agents of chromoblastomycosis (CBM), a chronic subcutaneous disease that is difficult to treat. This work aimed to evaluate the effects of copper(II), manganese(II) and silver(I) complexes coordinated with 1,10-phenanthroline (phen)/1,10-phenanthroline-5,6-dione (phendione) on Fonsecaea spp. Our results revealed that most of these complexes were able to inhibit F. pedrosoi, F. monophora and F. nubica conidial viability with minimum inhibitory concentration (MIC) values ranging from 0.6 to 100 µM. The most effective complexes against F. pedrosoi planktonic conidial cells, the main etiologic agent of CBM, were [Ag(phen)2]ClO4 and [Ag2(3,6,9-tdda)(phen)4].EtOH, (tdda: 3,6,9-trioxaundecanedioate), displaying MIC values equal to 1.2 and 0.6 µM, respectively. These complexes were effective in reducing the viability of F. pedrosoi biofilm formation and maturation. Silver(I)-tdda-phen, combined with itraconazole, reduced the viability and extracellular matrix during F. pedrosoi biofilm development. Moreover, both silver(I) complexes inhibited either metallo- or aspartic-type peptidase activities of F. pedrosoi as well as its conidia into mycelia transformation and melanin production. In addition, the complexes induced the production of intracellular reactive oxygen species in F. pedrosoi. Taken together, our data corroborate the antifungal action of metal-phen complexes, showing they represent a therapeutic option for fungal infections, including CBM.
- Open Access
The Anti-Leishmania amazonensis and Anti-Leishmania chagasi Action of Copper(II) and Silver(I) 1,10-Phenanthroline-5,6-dione Coordination Compounds
Leishmaniasis is a neglected disease caused by protozoa belonging to the Leishmania genus. Notably, the search for new, promising and potent anti-Leishmania compounds remains a major goal due to the inefficacy of the available drugs used nowadays. In the present work, we evaluated the effects of 1,10-phenanthroline-5,6-dione (phendione) coordinated to silver(I), [Ag(phendione)2]ClO4 (Ag-phendione), and copper(II), [Cu(phendione)3](ClO4)2·4H2O (Cu-phendione), as potential drugs to be used in the chemotherapy against Leishmania amazonensis and Leishmania chagasi. The results showed that promastigotes treated with Ag-phendione and Cu-phendione presented a significant reduction in the proliferation rate. The IC50 values calculated to Ag-phendione and Cu-phendione, respectively, were 7.8 nM and 7.5 nM for L. amazonensis and 24.5 nM and 20.0 nM for L. chagasi. Microscopical analyses revealed several relevant morphological changes in promastigotes, such as a rounding of the cell body and a shortening/loss of the single flagellum. Moreover, the treatment promoted alterations in the unique mitochondrion of these parasites, inducing significant reductions on both metabolic activity and membrane potential parameters. All these cellular perturbations induced the triggering of apoptosis-like death in these parasites, as judged by the (i) increased percentage of annexin-positive/propidium iodide negative cells, (ii) augmentation in the proportion of parasites in the sub-G0/G1 phase and (iii) DNA fragmentation. Finally, the test compounds showed potent effects against intracellular amastigotes; contrarily, these molecules were well tolerated by THP-1 macrophages, which resulted in excellent selective index values. Overall, the results highlight new selective and effective drugs against Leishmania species, which are important etiological agents of both cutaneous (L. amazonensis) and visceral (L. chagasi) leishmaniasis in a global perspective.
Open AccessThe Anti-Leishmania amazonensis and Anti-Leishmania chagasi Action of Copper(II) and Silver(I) 1,10-Phenanthroline-5,6-dione Coordination Compounds
Leishmaniasis is a neglected disease caused by protozoa belonging to the Leishmania genus. Notably, the search for new, promising and potent anti-Leishmania compounds remains a major goal due to the inefficacy of the available drugs used nowadays. In the present work, we evaluated the effects of 1,10-phenanthroline-5,6-dione (phendione) coordinated to silver(I), [Ag(phendione)2]ClO4 (Ag-phendione), and copper(II), [Cu(phendione)3](ClO4)2·4H2O (Cu-phendione), as potential drugs to be used in the chemotherapy against Leishmania amazonensis and Leishmania chagasi. The results showed that promastigotes treated with Ag-phendione and Cu-phendione presented a significant reduction in the proliferation rate. The IC50 values calculated to Ag-phendione and Cu-phendione, respectively, were 7.8 nM and 7.5 nM for L. amazonensis and 24.5 nM and 20.0 nM for L. chagasi. Microscopical analyses revealed several relevant morphological changes in promastigotes, such as a rounding of the cell body and a shortening/loss of the single flagellum. Moreover, the treatment promoted alterations in the unique mitochondrion of these parasites, inducing significant reductions on both metabolic activity and membrane potential parameters. All these cellular perturbations induced the triggering of apoptosis-like death in these parasites, as judged by the (i) increased percentage of annexin-positive/propidium iodide negative cells, (ii) augmentation in the proportion of parasites in the sub-G0/G1 phase and (iii) DNA fragmentation. Finally, the test compounds showed potent effects against intracellular amastigotes; contrarily, these molecules were well tolerated by THP-1 macrophages, which resulted in excellent selective index values. Overall, the results highlight new selective and effective drugs against Leishmania species, which are important etiological agents of both cutaneous (L. amazonensis) and visceral (L. chagasi) leishmaniasis in a global perspective.
- 9 December 2022
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 28 (2) , 153-171
Antibacterial activity of metal–phenanthroline complexes against multidrug-resistant Irish clinical isolates: a whole genome sequencing approach
Antimicrobial resistance (AMR) is one of the serious global health challenges of our time. There is now an urgent need to develop novel therapeutic agents that can overcome AMR, preferably through alternative mechanistic pathways from conventional treatments. The antibacterial activity of metal complexes (metal = Cu(II), Mn(II), and Ag(I)) incorporating 1,10-phenanthroline (phen) and various dianionic dicarboxylate ligands, along with their simple metal salt and dicarboxylic acid precursors, against common AMR pathogens were investigated. Overall, the highest level of antibacterial activity was evident in compounds that incorporate the phen ligand compared to the activities of their simple salt and dicarboxylic acid precursors. The chelates incorporating both phen and the dianion of 3,6,9-trioxaundecanedioic acid (tdda) were the most effective, and the activity varied depending on the metal centre. Whole-genome sequencing (WGS) was carried out on the reference Pseudomonas aeruginosa strain, PAO1. This strain was exposed to sub-lethal doses of lead metal-tdda-phen complexes to form mutants with induced resistance properties with the aim of elucidating their mechanism of action. Various mutations were detected in the mutant P. aeruginosa genome, causing amino acid changes to proteins involved in cellular respiration, the polyamine biosynthetic pathway, and virulence mechanisms. This study provides insights into acquired resistance mechanisms of pathogenic organisms exposed to Cu(II), Mn(II), and Ag(I) complexes incorporating phen with tdda and warrants further development of these potential complexes as alternative clinical therapeutic drugs to treat AMR infections. Graphical abstract
- 9 December 2022
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 28 (2) , 153-171
Antibacterial activity of metal–phenanthroline complexes against multidrug-resistant Irish clinical isolates: a whole genome sequencing approach
Antimicrobial resistance (AMR) is one of the serious global health challenges of our time. There is now an urgent need to develop novel therapeutic agents that can overcome AMR, preferably through alternative mechanistic pathways from conventional treatments. The antibacterial activity of metal complexes (metal = Cu(II), Mn(II), and Ag(I)) incorporating 1,10-phenanthroline (phen) and various dianionic dicarboxylate ligands, along with their simple metal salt and dicarboxylic acid precursors, against common AMR pathogens were investigated. Overall, the highest level of antibacterial activity was evident in compounds that incorporate the phen ligand compared to the activities of their simple salt and dicarboxylic acid precursors. The chelates incorporating both phen and the dianion of 3,6,9-trioxaundecanedioic acid (tdda) were the most effective, and the activity varied depending on the metal centre. Whole-genome sequencing (WGS) was carried out on the reference Pseudomonas aeruginosa strain, PAO1. This strain was exposed to sub-lethal doses of lead metal-tdda-phen complexes to form mutants with induced resistance properties with the aim of elucidating their mechanism of action. Various mutations were detected in the mutant P. aeruginosa genome, causing amino acid changes to proteins involved in cellular respiration, the polyamine biosynthetic pathway, and virulence mechanisms. This study provides insights into acquired resistance mechanisms of pathogenic organisms exposed to Cu(II), Mn(II), and Ag(I) complexes incorporating phen with tdda and warrants further development of these potential complexes as alternative clinical therapeutic drugs to treat AMR infections. Graphical abstract